About KPV - Antomicrobial Repair Peptide

KPV is a potent anti-inflammatory and antimicrobial tripeptide (derived from alpha-MSH) that works by entering cell nuclei to directly shut down inflammatory signaling. It's most commonly used to heal the gut lining (for issues like IBD, IBS, or leaky gut) and calm inflammatory skin conditions like eczema or psoriasis. While effective on its own, it is most popularly researched as part of the KLOW combo, which pairs KPV's gut and immune benefits with the full tissue-repair power of BPC-157, TB-500, and GHK-Cu.

WHAT THE RESEARCH SHOWS

KPV (Lysine-Proline-Valine) is a naturally occurring tripeptide derived from the C-terminal fragment of alpha-Melanocyte-Stimulating Hormone (α-MSH). While whole α-MSH controls skin pigmentation, research shows that KPV retains the parent hormone’s profound anti-inflammatory and antimicrobial properties without stimulating melanocortin-1 receptors (MC1R)—meaning it produces zero skin darkening or tanning. Here is what the published preclinical and cellular research shows:
* Direct Inhibition of the NF-κB Pathway: * KPV's primary anti-inflammatory mechanism is its ability to enter the cell and shut down NF-κB (nuclear factor kappa B)—the body's central genetic switch for inflammation.
* By blocking NF-κB translocation into the nucleus, it significantly halts the downstream cascade of pro-inflammatory cytokines, specifically TNF-α, IL-6, IL-1β, and IL-8.
* Targeted Gut Transport (The PepT1 Advantage): One of KPV's most remarkable features in gastrointestinal studies is how it enters intestinal cells. It is actively transported across cell membranes by PepT1 (peptide transporter 1).
* In conditions like Crohn's disease, ulcerative colitis, and chronic bowel inflammation, PepT1 expression is heavily upregulated in inflamed intestinal tissue. This allows KPV to naturally concentrate directly where mucosal inflammation and tissue damage are at their worst. * In animal models of colitis (such as DSS-induced colitis), KPV significantly reduced leukocyte infiltration, histological inflammation, and weight loss, while rapidly restoring intestinal epithelial integrity.
* Direct Antimicrobial & Antifungal Actions: Unlike most peptides that only modulate host immunity, research shows KPV exhibits direct antimicrobial properties.
* In microbiological assays, KPV demonstrated inhibitory and microbicidal effects against major pathogens, including Staphylococcus aureus and Candida albicans, disrupting pathogen viability without harming host tissue.
* Wound Healing & Scar Prevention:
* In dermatological research, KPV has been shown to downregulate inflammation in contact dermatitis and psoriasis-like skin models. * Furthermore, studies show it modulates the TGF-β1 pathway, which helps prevent excessive fibroblast differentiation into myofibroblasts. This translates to accelerated wound closure with a reduced risk of abnormal, hypertrophic scarring (keloids). * Mast Cell Stabilization:
* Studies indicate KPV helps suppress mast cell degranulation, meaning it can reduce histamine release and blunt runaway allergic or autoimmune inflammatory cascades.

The Bottom Line: Research establishes KPV not as a growth factor, but as a potent biological anti-inflammatory "fire extinguisher" with strong affinity for the gut lining and skin. Because KPV halts inflammation but doesn't directly stimulate blood vessel growth or collagen remodeling, it is often paired with structural peptides. For stubborn gut barrier issues or systemic inflammatory conditions, the KLOW combo (GLOW + KPV) provides the best of both worlds: KPV quenches the underlying inflammation while BPC-157, TB-500, and GHK-Cu actively rebuild the damaged tissue architecture.

STUDIES - All links

• Dalmasso et al. 2008 – KPV and gut inflammation (PMC)
• Kannengiesser et al. 2008 – KPV in IBD models
• Kannengiesser et al. 2008 – abstract
• Peptide Protocol Wiki – KPV research summary
• Superpower – KPV guide
• Viennois et al. – KPV and colitis-associated cancer
• Laroui et al. – KPV nanoparticles for colitis
• Dr Pat Taylor – KPV study summaries
• Outliyr – KPV report

Lyophilised powder